Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Master protocol for mantle cell lymphoma
2004-002860-43Phase 2Active
- Sponsor
- SIAK-Biotech
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of gemcitabine in mantle cell lymphoma (MCL), sponsored by SIAK-Biotech. Started Nov 2004; status: active.
02
Drugs
gemcitabine
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2004-002860-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002860-43.